SBC Medical Group Holdings Incorporated (SBC) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.
The consensus price target is $9.00, representing an upside of 106.4% from the current price $4.36.
Analysts estimate Earnings Per Share (EPS) of $0.59 and revenue of $0.22B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.48 vs est $0.59 (missed -18.6%). 2025: actual $0.50 vs est $0.46 (beat +9.4%). Analyst accuracy: 84%.
SBC Stock — 12-Month Price Forecast
$9.00
▲ +106.42% Upside
Average Price Target
Based on 1 Wall Street analysts offering 12-month price targets for SBC Medical Group Holdings Incorporated, the price target is $9.00.
The average price target represents a +106.42% change from the last price of $4.36.
SBC Analyst Ratings
Buy
Based on 1 analysts giving stock ratings to SBC Medical Group Holdings Incorporated in the past 3 months
EPS Estimates — SBC
84%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.48
vs Est $0.59
▼ 22.9% off
2025
Actual $0.50
vs Est $0.46
▲ 8.6% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is improving.
Revenue Estimates — SBC
95%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.205B
vs Est $0.218B
▼ 6.1% off
2025
Actual $0.174B
vs Est $0.179B
▼ 3.4% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
